$NRG Balance Sheet | Understand Stock

$NRG

$96.96 +$1.69 (1.77%) Live

$NRG Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD; shares in millions, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
ASSETS
Current Assets
Cash and cash equivalents
Funds deposited by counterparties
Restricted cash
Accounts receivable, net
Uplift securitization proceeds receivable from ERCOT
Inventory
Derivative instruments
Cash collateral paid in support of energy risk management activities
Prepayments and other current assets
Current assets - held-for-sale
Total current assets

Property, plant and equipment, net
Equity investments in affiliates
Other Assets
Operating lease right-of-use assets, net
Goodwill
Intangible assets, net
Customer Relationships
Other intangible assets, net
Total intangible assets, net
Nuclear decommissioning trust fund
Derivative instruments
Deferred income taxes
Other non-current assets
Non-current assets - held-for-sale
Total other assets
Total Assets
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current Liabilities
Current portion of long-term debt and finance leases
Current portion of operating lease liabilities
Accounts payable
Derivative instruments
Cash collateral received in support of energy risk management activities
Deferred revenue current
Accrued expenses and other current liabilities
Current liabilities - held-for-sale
Total current liabilities
Other Liabilities
Long-term debt and finance leases
Non-current operating lease liabilities
Nuclear decommissioning reserve
Nuclear decommissioning trust liability
Derivative instruments
Deferred income taxes
Deferred revenue non-current
Other non-current liabilities
Non-current liabilities - held-for-sale
Total other liabilities
Total Liabilities
Stockholders’ Equity
Preferred stock; 10,000,000 shares authorized; 650,000 Series A shares issued and outstanding at June 30, 2026 and December 31, 2025, aggregate liquidation preference of $650 at June 30, 2026 and December 31, 2025
Common stock; $0.01 par value; 500,000,000 shares authorized; 225,198,900 and 199,828,615 shares issued and 210,307,902 and 190,376,607 shares outstanding at June 30, 2026 and December 31, 2025, respectively
Additional paid-in-capital
Retained earnings
Treasury stock, at cost; 14,890,998 shares and 9,452,008 shares at June 30, 2026 and December 31, 2025, respectively
Accumulated other comprehensive loss
Total Stockholders’ Equity
Total Liabilities and Stockholders’ Equity
Treasury stock, shares (in shares)

Comments